The European healthcare technology and medical technology sectors have reached a definitive inflection point in 2026, transitioning from a period of venture-subsidised experimentation to an era of disciplined industrial maturity. This shift is characterized by a "Great Rationalization," where the market has moved past the speculative exuberance of the early 2020s and settled into a rigorous "flight to quality". Central to this transformation is the emergence of the "Founder B

Subconscious vibro-tactile stimulation (VTS) represents a powerful, emerging modality within the HealthTech sector, positioned to transition from a specialised clinical tool to a ubiquitous component of personalised healthcare. Defined as the application of non-invasive mechanical vibration to the skin to modulate neural activity, VTS operates on an implicit level, leveraging the body's natural sensory and proprioceptive systems to effect therapeutic changes in the brain and